Immunotherapy-Responsive Post COVID-19 Central Nervous System Inflammatory Syndrome, a Case Report
Background: COVID 19 virus can infect the central and peripheral nervous system with or without other systemic manifestations of infection....
Case Report: Lama-2 Related Muscular Dystrophy Mimicking Multiple Sclerosis
Background: There is increased prevalence of genetic testing within the field of neurology and provider awareness of genetic conditions...
Bad Lettuce? Frozen Vegetables? Undercooked Steak? Case Report of Systemic Listeria Monocytogenes Infection in a Patient on Dimethyl Fumarate
Background: The use of disease modifying treatments (DMTs) in multiple sclerosis (MS) has been well studied and has shown to reduce...
Identifying and Treating Steroid-Induced Psychosis in MS Patients Using Quetiapine
Background: High-dose corticosteroids (CS) (1g IV methylprednisolone or 1250 mg oral prednisone for 3-5 days) is the most common treatment...
Delayed Visual Improvement in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis
Background: Bilateral involvement and severe visual impairment can occur in the acute phase of pediatric myelin oligodendrocyte...
Treating Minority Patients with Multiple Sclerosis: Development of the CHIMES Trial
Background: Black, African American (AA) and Hispanic/Latino (HA) patients with multiple sclerosis (MS) have greater disease severity and...
The Art of the Patient Conversation: Advanced Practice Provider Perspectives to Improve Outcomes in Multiple Sclerosis
Background: Robust health literacy, defined by the Centers for Disease Control and Prevention as the degree to which an individual can...
A Description of Real-World MRI Acquired in Patients with Multiple Sclerosis: Preliminary Insights from FlywheelMS
Background: Magnetic resonance imaging (MRI) in the context of routine care is an important tool that can inform clinical decisions in...